**Question:** Advantages of ultrasound nuchal translucency over biochemical screening for Down syndrome include:

A. Improved detection rate of Down syndrome cases
B. Earlier detection of Down syndrome
C. Increased specificity for Down syndrome diagnosis
D. Lower false positive rate compared to biochemical screening

**Core Concept:** Nuchal translucency (NT) measurement is an ultrasound-based assessment performed in the first trimester of pregnancy to evaluate for an elevated risk of fetal chromosomal abnormalities, particularly trisomy 21 (Down syndrome). Biochemical screening involves measuring specific blood markers to estimate the risk of Down syndrome.

**Why the Correct Answer is Right:**

1. Improved detection rate of Down syndrome cases: Ultrasound nuchal translucency assessment directly visualizes the increased fluid accumulation in the nuchal region, which is characteristic of a higher risk of Down syndrome. This provides a more accurate diagnosis compared to biochemical screening, which relies on blood tests.
2. Earlier detection of Down syndrome: Nuchal translucency assessment can be performed during the first trimester, providing earlier detection than biochemical screening, which is usually done in the second trimester.
3. Increased specificity for Down syndrome diagnosis: Nuchal translucency measurement reduces the likelihood of false positives, which can be seen with biochemical screening due to the influence of other factors on blood marker levels.
4. Lower false positive rate compared to biochemical screening: Nuchal translucency assessment has a higher diagnostic accuracy, reducing the number of unnecessary follow-up tests and interventions required for patients with a high risk of Down syndrome.

**Why Each Wrong Option is Incorrect:**

A. Improved sensitivity is not one of the advantages of ultrasound nuchal translucency over biochemical screening for Down syndrome. While both methods aim to detect Down syndrome, nuchal translucency assessment offers specific advantages over biochemical screening, such as improved specificity and lower false positive rates.
B. Earlier detection is a correct advantage of nuchal translucency assessment, but it is not the primary reason for its superiority over biochemical screening. The key advantages lie in improved detection accuracy, specificity, and false positive rate.
C. Specificity is a correct advantage of nuchal translucency assessment but it is not a standalone benefit over biochemical screening. The primary advantages of nuchal translucency assessment involve improved detection accuracy, false positive rate, and specificity.
D. Lower false positive rate is a correct advantage of nuchal translucency assessment but it is not the primary reason for its superiority over biochemical screening. The key advantages lie in improved detection accuracy, specificity, and false positive rate.

**Clinical Pearl:** Ultrasound nuchal translucency assessment is a valuable tool in prenatal screening for Down syndrome, as it provides better detection accuracy, lower false positive rates, and higher specificity compared to biochemical screening methods. This allows for more precise risk assessment and targeted further testing, ultimately improving patient care and outcomes.